Thermo Fisher Scientific Life Sciences Solutions — Selling, general and administrative expenses decreased by 1.1% to $470.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 1.1%, from $475.00M to $470.00M. This is a positive signal — lower values indicate better performance for this metric.
Lower ratios relative to revenue suggest better operational leverage and administrative efficiency.
The operating costs incurred by the Life Sciences Solutions segment that are not directly tied to production, including...
Standard operating expense category for all corporate segments.
tmo_segment_life_sciences_solutions_selling_general_and_administrative_expenses| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q3 '25 | |
|---|---|---|---|---|---|---|
| Value | $441.50M | $441.50M | $441.50M | $441.50M | $475.00M | $470.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +7.6% | -1.1% |
| YoY Change | — | — | — | — | +7.6% | -1.1% |
We use cookies for analytics. See our Privacy and Cookie Policy.